New compounds may aid in development
of targeted therapies for a rare pediatric cancer

Learn More

Translational sarcoma therapeutics

Grohar Laboratory
The goal of our laboratory is to develop and clinically translate novel targeted therapies for pediatric sarcomas to improve patient outcomes. We employ a bench to bedside and back again approach to identify, characterize and develop new compounds and
drug combinations for Ewing sarcoma.

Learn More


Congratulations to Matt Harlow, Jennifer Jess and Guillermo Flores, who attended Michigan State University’s Pediatric Research Day in March and took home three out of five poster awards out of 77 posters overall!



We are always looking to recruit lab members at all levels. Please contact Dr. Grohar with questions.

Related Links

Spectrum Health Helen DeVos Children’s Hospital

Michigan State University College of Human Medicine

Children’s Oncology Group (Steering Committee member and vice chair of the Ewing Sarcoma Biology Committee)

SARC (member of the Developmental Therapeutics Committee)